Aspire Biopharma Holdings, Inc. (ASBP)
0.0959
-0.01
(-8.23%)
USD |
NASDAQ |
Dec 12, 16:00
0.117
+0.02
(+22.00%)
After-Hours: 20:00
Aspire Biopharma Holdings Total Assets (Quarterly): 2.403M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Salarius Pharmaceuticals, Inc. | 6.097M |
| Taysha Gene Therapies, Inc. | 316.55M |
| Olema Pharmaceuticals, Inc. | 352.45M |
| Invivyd, Inc. | 139.16M |
| MSP Recovery, Inc. | 1.552B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 13.87M |
| Shareholders Equity (Quarterly) | -11.47M |
| Debt to Equity Ratio | -0.7521 |
| Current Ratio | 0.1734 |
| Net Debt Paydown Yield | -6.41% |